Details of the Drug Reposition

General Information of This Drug (ID: DMFX9O6)

Drug Name
SM-101   DMFX9O6
Synonyms SMP-534
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved (orphan drug) Indication(s)
Indication Name Indication ID ICD-11 Status REF
Idiopathic thrombocytopenic purpura DISFKGJU 3B64.10 Approved (orphan drug) [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Systemic lupus erythematosus DISI1SZ7 4A40.0 Phase 2 [2]
------------------------------------------------------------------------------------
1 Preclinical Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diabetic nephropathy DIS2FCCT GB61.Z Preclinical [3]
------------------------------------------------------------------------------------

References

1 Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Agents in development for the treatment of diabetic nephropathy. Expert Opin Emerg Drugs. 2008 Sep;13(3):447-63.